Description
- The drug Cytarabine, in combination with other approved anti-cancer drugs, is recommended for remission induction in acute non-lymphocytic leukemia patients.
- This medicine has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia.Â
- Intrathecal administration of Cytarabine is recommended in the prophylaxis and treatment of meningeal leukemia.Â
Cytarabine 100 mg is an antineoplastic, a sterile solution of cytarabine for intravenous, intrathecal, or subcutaneous administration.
Dosage and Side Effects
- Healthcare Professionals may give Cytarabine Injection by intravenous infusion or injection, subcutaneously, or intrathecally (preservative-free preparation only).Â
- Patients can tolerate higher total doses when they receive the drug by rapid intravenous injection as compared with slow infusion.Â
- In the induction therapy of acute non-lymphocytic leukemia, the usual cytarabine dose in combination with other anti-cancer drugs is 100 mg/m2/day by continuous intravenous infusion (Days 1-7) or 100 mg/m2 intravenous every 12 hours (Days 1-7). The literature should be consulted for the current recommendations for use in acute lymphocytic leukemia.Â
- Cytarabine injection has been used intrathecally in acute leukemia in doses ranging from 5 mg/m2 to 75 mg/m2 of body surface area. The frequency of administration varied from once a day for 4 days to once every 4 days.
Cytarabine’s common side effects include anorexia, oral and anal inflammation, rash, nausea, thrombophlebitis, vomiting, hepatic dysfunction, bleeding, diarrhea, and fever.
Warning and Precautions
The medical professional should monitor the patients receiving Cytarabine Injection closely. Frequent platelet and leucocyte counts and bone marrow examinations are mandatory.
There is a report of acute pancreatitis in a patient receiving Cytarabine by continuous infusion and in patients being treated with Cytarabine Injection who have had prior treatment with L-asparaginase.Â
The drug Cytarabine is a potent bone marrow suppressant. Therapy should be started cautiously in patients with pre-existing drug-induced bone marrow suppression. One should keep the patients receiving this drug under close medical supervision and, during induction therapy, should have leucocyte and platelet counts performed daily.
Cytarabine medicine can cause fetal harm when administered to a pregnant woman. This drug causes abnormal cerebellar development in the neonatal hamster and is teratogenic to the rat fetus.
There are reports of severe and, at times, fatal CNS, GI, and pulmonary toxicity following some experimental dose schedules for cytarabine 1000 mg injection.
FAQ's
What is Cytarabine used for?
The drug Cytarabine is used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML).Â
Is Cytarabine a chemotherapy medicine?
The medicine Cytarabine is a type of chemotherapy drug called an antimetabolite. This medicine kills cancer cells by stopping them from making and repairing DNA that they need to grow and multiply.
How much does Cytarabine cost?
The Cytarabine cost is reasonable, and one can readily purchase this medicine from any certified pharmaceutical supplier.Â
Where can I get Cytarabine at the best Price?Â
Order Cytarabine injection at the best price today. We request you to Call/WhatsApp us at (+91) 8130290915 or dial our TOLL-FREE Number: 1800-889-1064 or Write us at info@indiangenericmedicines.com. We’re fully committed to providing you with the best Cytarabine price from India. That is why we’ll match the cost/price of any other existing facilitators/suppliers/distributors in the market who require a valid medical prescription.
